101 related articles for article (PubMed ID: 17094135)
1. Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity.
Zastre J; Jackson JK; Wong W; Burt HM
J Pharm Sci; 2007 Apr; 96(4):864-75. PubMed ID: 17094135
[TBL] [Abstract][Full Text] [Related]
2. Evidence for modulation of P-glycoprotein-mediated efflux by methoxypolyethylene glycol-block-Polycaprolactone amphiphilic diblock copolymers.
Zastre J; Jackson J; Burt H
Pharm Res; 2004 Aug; 21(8):1489-97. PubMed ID: 15359586
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers.
Zastre J; Jackson J; Bajwa M; Liggins R; Iqbal F; Burt H
Eur J Pharm Biopharm; 2002 Nov; 54(3):299-309. PubMed ID: 12445560
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein efflux inhibition by amphiphilic diblock copolymers: relationship between copolymer concentration and substrate hydrophobicity.
Zastre JA; Jackson JK; Wong W; Burt HM
Mol Pharm; 2008; 5(4):643-53. PubMed ID: 18380467
[TBL] [Abstract][Full Text] [Related]
6. Inhibition mechanism of P-glycoprotein mediated efflux by mPEG-PLA and influence of PLA chain length on P-glycoprotein inhibition activity.
Li W; Li X; Gao Y; Zhou Y; Ma S; Zhao Y; Li J; Liu Y; Wang X; Yin D
Mol Pharm; 2014 Jan; 11(1):71-80. PubMed ID: 24256068
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.
Collnot EM; Baldes C; Wempe MF; Kappl R; Hüttermann J; Hyatt JA; Edgar KJ; Schaefer UF; Lehr CM
Mol Pharm; 2007; 4(3):465-74. PubMed ID: 17367162
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin.
Vilas-Boas V; Silva R; Nunes C; Reis S; Ferreira L; Vieira C; Carvalho F; Bastos Mde L; Remião F
Toxicol Lett; 2013 Jul; 220(3):259-66. PubMed ID: 23685082
[TBL] [Abstract][Full Text] [Related]
9. Effects of detergents on P-glycoprotein atpase activity: differences in perturbations of basal and verapamil-dependent activities.
Orlowski S; Selosse MA; Boudon C; Micoud C; Mir LM; Belehradek J; Garrigos M
Cancer Biochem Biophys; 1998 Jun; 16(1-2):85-110. PubMed ID: 9923970
[TBL] [Abstract][Full Text] [Related]
10. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
11. Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation.
Khamenehfar A; Wan CP; Li PC; Letchford K; Burt HM
Anal Bioanal Chem; 2014 Nov; 406(28):7071-83. PubMed ID: 25315452
[TBL] [Abstract][Full Text] [Related]
12. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
Rege BD; Kao JP; Polli JE
Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
[TBL] [Abstract][Full Text] [Related]
13. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
Letchford K; Liggins R; Wasan KM; Burt H
Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
[TBL] [Abstract][Full Text] [Related]
14. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.
Hugger ED; Novak BL; Burton PS; Audus KL; Borchardt RT
J Pharm Sci; 2002 Sep; 91(9):1991-2002. PubMed ID: 12210046
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy.
Mohanty C; Acharya S; Mohanty AK; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2010 Apr; 5(3):433-49. PubMed ID: 20394536
[TBL] [Abstract][Full Text] [Related]
16. Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations.
Letchford K; Liggins R; Burt H
J Pharm Sci; 2008 Mar; 97(3):1179-90. PubMed ID: 17683080
[TBL] [Abstract][Full Text] [Related]
17. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
[TBL] [Abstract][Full Text] [Related]
18. Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers.
Hugger ED; Audus KL; Borchardt RT
J Pharm Sci; 2002 Sep; 91(9):1980-90. PubMed ID: 12210045
[TBL] [Abstract][Full Text] [Related]
19. Effects of monoglycerides on P-glycoprotein: modulation of the activity and expression in Caco-2 cell monolayers.
Barta CA; Sachs-Barrable K; Feng F; Wasan KM
Mol Pharm; 2008; 5(5):863-75. PubMed ID: 18651749
[TBL] [Abstract][Full Text] [Related]
20. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2.
Yoo HH; Lee M; Lee MW; Lim SY; Shin J; Kim DH
Planta Med; 2007 May; 73(5):444-50. PubMed ID: 17566147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
